Latest AI and machine learning research in skin cancer for healthcare professionals.
Gefitinib resistance (GR) presents a significant challenge in treating lung adenocarcinoma (LUAD), highlighting the need for alternative therapies. This study explores the genetic basis of GR to improve prediction, prevention, and treatment strategies. We utilized public databases to obtain GR gene sets, single-cell data, and transcriptome data, applying univariate and multivariate regression anal...
This paper aims to address the pressing issue of melanoma classification by leveraging advanced neural network models, specifically basic Convolutional Neural Networks (CNN), ResNet-18, and EfficientNet-B0. Our objectives encompass presenting and evaluating these models based on established practices in medical image diagnosis. Additionally, we aim to demonstrate their effectiveness in contributin...
RATIONALE AND OBJECTIVES: To develop and validate multiple machine learning predictive models incorporating clinical features and pretreatment multipa...
Immune checkpoint inhibitors (ICIs) are revolutionizing cancer treatment, and Artificial Intelligence (AI) is a key player in this field. A comprehens...
Cancer immunotherapy has emerged as a novel clinical therapeutic option for a variety of solid tumors over the past decades. The application of immuno...
The characteristics of neutrophils play a crucial role in defining the tumor inflammatory environment. However, the function of tumor-associated neutr...
Single-cell mass spectrometry (SCMS) is an emerging tool for studying cell heterogeneity according to variation of molecular species in single cells. ...
BACKGROUND AND OBJECTIVE: Treatment approaches for colorectal cancer (CRC) are highly dependent on the molecular subtype, as immunotherapy has shown e...
SIGNIFICANCE: Early detection of melanoma is crucial for improving patient outcomes, and dermoscopy is a critical tool for this purpose. However, hair...
BACKGROUND: Tumor Mutational Burden (TMB) have emerged as pivotal predictive biomarkers in determining prognosis and response to immunotherapy in colo...
Anoikis-related genes (ANRGs) are crucial in the invasion and metastasis of breast cancer (BC). The underlying role of ANRGs in the prognosis of brea...
Skin cancer is the most common type of cancer in the United States and is estimated to affect one in five Americans. Recent advances have demonstrated...
BACKGROUND: Interferon-alpha1b (IFN-α1b) has shown remarkable therapeutic potential as adjuvant therapy for melanoma. This study aimed to develop five...
Skin cancer (SC) is one of the three most common cancers worldwide. Melanoma has the deadliest potential to spread to other parts of the body among al...
Pancreatic cancer remains one of the most lethal cancers, primarily due to its late diagnosis and limited treatment options. This review examines the ...
Immunotherapy has ushered in a new era of cancer treatment, yet cancer remains a leading cause of global mortality. Among various therapeutic strategi...
In this study, we aimed to investigate disparities in the tumor immune microenvironment (TME) between primary and metastatic malignant melanoma (MM) u...
The digitization of health records and growing availability of tumour DNA sequencing provide an opportunity to study the determinants of cancer outcom...
Early detection and treatment of skin cancer are important for patient recovery and survival. Dermoscopy images can help clinicians for timely identif...
Viruses are widely recognized to be intricately associated with both solid and hematological malignancies in humans. The primary goal of this research...